UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

The European respiratory journal, 2016-01, Vol.47 (1), p.45-68

2016

Volltextzugriff (PDF)

Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris

The European respiratory journal, 2017-08, Vol.50 (2), p.1602419-1602419

2017

Volltextzugriff (PDF)

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

The lancet oncology, 2009-12, Vol.10 (12), p.1152-1159

2009

Volltextzugriff (PDF)

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

The Lancet (British edition), 2016-04, Vol.387 (10026), p.1415-1426

2016

Volltextzugriff (PDF)

Lung cancer is also a hereditary disease

European respiratory review, 2021-12, Vol.30 (162), p.210045

2021

Volltextzugriff (PDF)

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

The European respiratory journal, 2017-08, Vol.50 (2), p.1700050-1700050

2017

Volltextzugriff (PDF)

Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages

Lung cancer (Amsterdam, Netherlands), 2016-08, Vol.98, p.51-58

2016

Volltextzugriff (PDF)

Lung cancer and interstitial lung disease: a literature review

Journal of thoracic disease, 2018-06, Vol.10 (6), p.3829-3844

2018

Volltextzugriff (PDF)

Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis

Thorax, 2018-02, Vol.73 (2), p.145-150

2018

Volltextzugriff (PDF)

Pulmonary mucosa-associated lymphoid tissue lymphoma revisited

The European respiratory journal, 2016-04, Vol.47 (4), p.1244-1260

2016

Volltextzugriff (PDF)

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

Journal of clinical oncology, 2008-09, Vol.26 (27), p.4410-4417

2008

Volltextzugriff (PDF)

Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities

Autoimmunity reviews, 2020-08, Vol.19 (8), p.102586, Article 102586

2020

Volltextzugriff (PDF)

Lymphoproliferative Disorders of the Lung

Respiration, 2017-01, Vol.94 (2), p.157-175

2017

Volltextzugriff (PDF)

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

European respiratory review, 2019-09, Vol.28 (153), p.190058

2019

Volltextzugriff (PDF)

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study

Lung cancer (Amsterdam, Netherlands), 2019-11, Vol.137, p.149-156

2019

Volltextzugriff (PDF)

Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives

Respiration, 2018-01, Vol.96 (2), p.159-170

2018

Volltextzugriff (PDF)

The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population

PloS one, 2013-08, Vol.8 (8), p.e70621-e70621

2013

Volltextzugriff (PDF)

Therapeutic strategy for advanced EGFR mutant non-small-cell lung carcinoma

Critical reviews in oncology/hematology, 2013-12, Vol.88 (3), p.477-493

2013

Volltextzugriff (PDF)

Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2023-12, Vol.186, p.107393-107393, Article 107393

2023

Volltextzugriff (PDF)

Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis

BMC medicine, 2017-10, Vol.15 (1), p.193-193, Article 193

2017

Volltextzugriff (PDF)

Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options

Journal of medical genetics, 2020-02, Vol.57 (2), p.104-108

2020

Volltextzugriff (PDF)

Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients

Scientific reports, 2022-06, Vol.12 (1), p.9502-9502, Article 9502

2022

Volltextzugriff (PDF)

Dramatic Radiation Recall Pneumonitis Induced by Osimertinib after Palliative Thoracic Radiotherapy for Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.e224-e226

2019

Volltextzugriff (PDF)

Chronic Pulmonary Aspergillosis: An Update on Diagnosis and Treatment

Respiration, 2014-01, Vol.88 (2), p.162-174

2014

Volltextzugriff (PDF)

1 – 25 von 553

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(493)
Mit Volltextzugriff
(473)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Lung cancer is also a hereditary disease

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages

Lung cancer and interstitial lung disease: a literature review

Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis

Pulmonary mucosa-associated lymphoid tissue lymphoma revisited

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities

Lymphoproliferative Disorders of the Lung

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study

Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives

The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population

Therapeutic strategy for advanced EGFR mutant non-small-cell lung carcinoma

Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)

Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis

Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options

Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients

Dramatic Radiation Recall Pneumonitis Induced by Osimertinib after Palliative Thoracic Radiotherapy for Lung Cancer

Chronic Pulmonary Aspergillosis: An Update on Diagnosis and Treatment

Suchergebnisse filtern